CytoMed Therapeutics Has Obtained Board Approval To Launch, Pilot Program To Isolate And Cryo-Store Peripheral Blood Mononuclear Cells For And As A Reward To Loyal Shareholders Of CytoMed On Complimentary Basis, The Program Will Commence On June 1, 2024
CytoMed Therapeutics已获得董事会批准启动试点计划，该计划将于2024年6月1日启动，该计划将分离和冷冻储存外周血单个核细胞，作为对CytoMed忠实股东的免费奖励